The Slow Privatisation of the NHS Must Stop Now

The National Health Service is being privatised. Not in a single dramatic moment that might provoke mass resistance, but gradually, contract by contract, service by service, in a process so incremental that each individual step can be defended as pragmatic or temporary. By the time the cumulative effect becomes undeniable, the architecture of a fully public health service may be too fragmented to rebuild. That process needs to stop, and it needs to stop now.

The numbers: privatisation by stealth

Start with what is measurable. Private sector involvement in NHS service delivery—meaning private companies contracted to provide care that was previously delivered directly by NHS trusts—has grown from approximately 4.6% of the total NHS budget in 2010 to over 9% by 2024, according to analysis by the King's Fund and Nuffield Trust drawing on Department of Health and Social Care accounts. That is not a marginal shift. It represents a doubling of the private share in just over a decade, and the trajectory shows no sign of slowing.

This is not about private pharmaceutical companies supplying drugs, or construction firms building hospitals, which have always been part of the NHS ecosystem. This is about the provision of clinical care itself—diagnostics, elective surgery, community services, even some emergency pathways—being transferred from public to private hands under contracts that embed private providers as permanent features of the system rather than temporary overflow capacity.

What the 2012 Act actually did

The legal foundation for this shift was the Health and Social Care Act 2012, which removed the requirement for NHS commissioners to prefer NHS providers and introduced a duty to put services out to competitive tender. The stated aim was to drive efficiency and innovation. The actual effect has been to fragment care pathways, introduce perverse incentives, and create a two-tier system within the NHS itself.

Private providers operating under NHS contracts are not subject to the same transparency requirements as NHS trusts. They do not have to publish board minutes, respond to Freedom of Information requests in the same way, or meet the same standards of public accountability. When things go wrong—and they do—the lines of responsibility are muddied. When they go right, the profit leaves the system entirely rather than being reinvested in care.

"The 2012 Act was sold as modernisation. What it actually did was turn the NHS into a marketplace, and in any marketplace, the incentive is not to provide the best care but to maximise profit within the contract terms. Those two things are not the same." — A view increasingly reflected in King's Fund and Nuffield Trust analysis of post-2012 outcomes.

Cherry-picking and the sustainability crisis

Here is what happens in practice. Private providers bid for contracts to deliver specific, high-volume, relatively straightforward procedures—cataract surgery, hip replacements, routine diagnostics. These are profitable because they are predictable, low-risk, and can be delivered at scale with standardised protocols. What they do not bid for is complex, unpredictable, high-cost care: emergency trauma, long-term chronic disease management, mental health crisis intervention.

The result is that NHS trusts are left with a patient mix that is systematically more expensive and more difficult to treat, while the revenue from simpler, profitable work flows to private providers. This is not a hypothetical concern. King's Fund research has documented this pattern repeatedly. It is called cream-skimming, and it makes the NHS as a whole less financially sustainable, not more.

The political defence is that private providers are meeting unmet demand and clearing backlogs. But the backlogs exist in large part because of sustained underfunding. The UK spends less on healthcare as a share of GDP than France, Germany, or the Netherlands, all of which have better health outcomes on most major indicators. Privatisation is being used to paper over a funding gap that is a political choice, not an economic necessity.

The workforce impact

There is also a human cost that does not show up neatly in budget spreadsheets. Staff working for private providers delivering NHS services are often employed on worse terms than their counterparts in NHS trusts. Lower pay, weaker pensions, less job security. This is not an accident. It is part of the business model. Private firms can undercut NHS bids precisely because they pay their staff less and invest less in training and development.

The long-term effect is to degrade the workforce. Experienced clinicians leave for better conditions. Training pipelines weaken because private providers have less incentive to invest in long-term workforce development—they can simply recruit ready-trained staff from the NHS itself. The system cannibalises itself, and the quality of care suffers.

Public satisfaction is collapsing

Public satisfaction with the NHS, tracked by the British Social Attitudes Survey, has fallen to some of the lowest levels since the survey began. In 2023, just 24% of respondents said they were satisfied with the NHS overall, down from a peak of 70% in 2010. That collapse has coincided almost exactly with the period of accelerating privatisation and sustained underfunding.

It is not a coincidence. People can feel the fragmentation. They experience it as longer waits, more bureaucratic complexity, less continuity of care. The NHS was built on the principle of comprehensive, integrated care free at the point of use. What is emerging in its place is a fragmented patchwork of providers with different incentives, different accountability structures, and different priorities. That is not the NHS. It is something else wearing the NHS logo.

The argument for reversal

The case for reversing this trajectory is not nostalgic or ideological. It is practical. The evidence is now clear: privatisation has not improved efficiency, has not reduced waiting times in any sustained way, and has not delivered better outcomes. What it has delivered is profit extraction, workforce degradation, and systemic fragmentation.

The alternative is not complicated. Fund the NHS properly—at levels comparable to other high-income European countries. Bring contracted-out services back in-house as contracts expire. Repeal the competitive tendering requirements of the 2012 Act. Rebuild integrated care pathways under public control. Invest in the workforce with terms and conditions that retain experienced staff and attract new talent.

None of this is radical. It is a return to the founding principles of the NHS, updated for the 21st century but grounded in the same logic: that healthcare is a public good, not a market commodity, and that the best way to deliver it is through a properly funded, publicly accountable, integrated system.

What happens if we don't

If the current trajectory continues, the NHS in any meaningful sense will not survive another decade. What will remain is a logo, a brand, and a fragmented collection of public and private providers with no coherent accountability, no integrated care pathways, and no mechanism to prevent the system from stratifying into a two-tier model where those who can afford it top up with private insurance and everyone else makes do with what is left.

That is not speculation. It is the observable direction of travel. And it is a political choice, not an inevitability. The question is whether there is the political will to stop it before the damage becomes irreversible.

The bottom line

The slow privatisation of the NHS is not modernisation. It is not efficiency. It is the dismantling of one of the most successful public institutions in British history, driven by ideology and enabled by underfunding. The evidence is clear, the trajectory is unsustainable, and the time to reverse it is now—before the fragmentation becomes permanent and the principle of universal, comprehensive, publicly provided healthcare is lost for good.